User:GuillaumeAdelmant: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
No edit summary
 
m (typo)
 
(One intermediate revision by one other user not shown)
Line 1: Line 1:
Current Position: Former EMBO Post-Doctoral Fellow, currently funded through a Novartis grant
Guillaume is now a Research Associate at Dana Farber Cancer Institute in the Dept of Cancer Biology with Jarrod Marto.


I am studying the mammalian protein arginine methyltransferases, with a special interest in understanding their role in signal transduction pathways, more specifically in neurons. I received my Ph.D. from the Institut Pasteur/Lille University (lab of Dr. D. Stehelin) on viral and cellular oncogenes. During my Ph.D., I did a short stay in the lab of Dr. Svend Freytag (Henry Ford Hospital) where I studied the TLS-CHOP oncogene.
I am studying the mammalian protein arginine methyltransferases, with a special interest in understanding their role in signal transduction pathways, more specifically in neurons. I received my Ph.D. from the Institut Pasteur/Lille University (lab of Dr. D. Stehelin) on viral and cellular oncogenes. During my Ph.D., I did a short stay in the lab of Dr. Svend Freytag (Henry Ford Hospital) where I studied the TLS-CHOP oncogene.

Latest revision as of 15:00, 1 March 2008

Guillaume is now a Research Associate at Dana Farber Cancer Institute in the Dept of Cancer Biology with Jarrod Marto.

I am studying the mammalian protein arginine methyltransferases, with a special interest in understanding their role in signal transduction pathways, more specifically in neurons. I received my Ph.D. from the Institut Pasteur/Lille University (lab of Dr. D. Stehelin) on viral and cellular oncogenes. During my Ph.D., I did a short stay in the lab of Dr. Svend Freytag (Henry Ford Hospital) where I studied the TLS-CHOP oncogene.